Anthrax Vaccine: Safety and Efficacy Issues

Abstract

We are pleased to be here today to discuss the results of our ongoing examination of the safety and efficacy of the anthrax vaccine. My testimony is based on previous studies we have conducted to determine (1) the need for a six-shot regimen and annual booster shots, (2) the long- and short-term safety of the vaccine, (3) the efficacy of the vaccine and (4) the extent to which problems the Food and Drug Administration (FDA) found in the vaccine production facility in Michigan could compromise the safety, efficacy, and quality of the vaccine. Finally, I would like to discuss the effects of the anthrax vaccine on children, pregnant women or lactating women.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 12, 1999
Accession Number
AD1177465

Entities

People

  • Kwai-cheung Chan

Organizations

  • United States Government Accountability Office

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Animals
  • Commerce
  • Deficiencies
  • Electronic Mail
  • Health
  • Health Care
  • Health Services
  • Immunity
  • Immunization
  • Medical Personnel
  • Military Personnel
  • Passive Surveillance
  • Public Health
  • Rodents
  • Side Effects
  • Surveys
  • United States
  • Vaccination
  • Vaccines

Fields of Study

  • Medicine

Readers

  • Immunology
  • Oncology
  • Systems Analysis and Design

Technology Areas

  • Biotechnology